Skip to content
Listen
Newsletters
Shows
Marketplace
Marketplace Morning Report
Marketplace Tech
Make Me Smart
This is Uncomfortable
The Uncertain Hour
How We Survive
Financially Inclined
Million Bazillion
Marketplace Minute®
Corner Office from Marketplace
Marketplace Logo
Newsletters
Shows
Marketplace
Marketplace Morning Report
Marketplace Tech
Make Me Smart
This is Uncomfortable
The Uncertain Hour
How We Survive
Financially Inclined
Million Bazillion
Marketplace Minute®
Corner Office from Marketplace
Facebook
Instagram
Youtube
TikTok
Donate
Search
Menu
Menu
Search
Explore
Latest Stories
Our Shows
Collections
Smart Speaker Skills
Music
Corrections
Company
About Us
Staff
Ethics Policy
Submissions
FAQs
Careers
Support Us
Individuals
Corporate Sponsorship
Foundations
Shop
Follow Us
Facebook
Instagram
Youtube
TikTok
Newsletters
Events
Talk to Us
Tricks of the Trade
Trump's Second Term
My Economy
I've Always Wondered ...
Your browser does not support the audio format.
Loading...
More From This Show
0:00
/
0:00
0% played
Support the fact-based journalism you rely on with a donation to Marketplace today.
Give Now!
Stories Tagged as
Biosimilars
The biggest middleman in the prescription drug supply chain now makes drugs
by
Lillian Karabaic
May 14, 2024
With pharmaceutical mergers more common, the FTC is taking a hard look at pharmacy benefit managers and antitrust concerns.
Brendan Smialowski/AFP via Getty Images
Listen
LISTEN
Download
Download
READ MORE
READ MORE
HTML EMBED:
<iframe id="mp_1095619" title="Marketplace Embed" src="https://www.marketplace.org/2024/05/14/cvs-pharmacy-prescription-benefit-manager-drug-supply-chain-manufacturing//popout" frameborder="0" width="100%" height="240px"></iframe>
COPY
EMBED
EMBED
Share Now on:
Facebook
Twitter
LinkedIn
Email
https://www.marketplace.org/2024/05/14/cvs-pharmacy-prescription-benefit-manager-drug-supply-chain-manufacturing/
COPY THE LINK
SHARE
SHARE
Subscribe Using:
Apple
Spotify
Amazon Music
Stitcher
RSS
SUBSCRIBE
SUBSCRIBE
Is competition the solution to high drug prices?
by
Dan Gorenstein
Jun 14, 2017
A recent U.S. Supreme Court ruling supports a new class of generic drugs.
Joe Raedle/Getty Images
Listen
LISTEN
Download
Download
READ MORE
READ MORE
HTML EMBED:
<iframe id="mp_74467" title="Marketplace Embed" src="https://www.marketplace.org/2017/06/14/is-competition-the-solution-to-high-drug-prices//popout" frameborder="0" width="100%" height="240px"></iframe>
COPY
EMBED
EMBED
Share Now on:
Facebook
Twitter
LinkedIn
Email
https://www.marketplace.org/2017/06/14/is-competition-the-solution-to-high-drug-prices/
COPY THE LINK
SHARE
SHARE
Subscribe Using:
Apple
Spotify
Amazon Music
Stitcher
RSS
SUBSCRIBE
SUBSCRIBE
